AstroCardia project: Belgium embarks on a mission to send to the ISS a 3D bioprinted heart model

AstroCardia Mission Control Centre - Credit: AstroCardia

A consortium of five Belgian companies embarks on a mission to improve heart health in space. Space Applications Services, SCK CEN, QbD Group, BIO INX and Antleron will study heart ageing through the AstroCardia project, and ambition to create a suitable research model for the heart.

To do so, they will develop an artificial miniature heart and associated circulatory system using 3D bioprinting in space, an environment conducive to investigate heart ageing. Called “heart-on-a-chip”, the model will be sent to the International Space Station (ISS) in 2025.

Treating cardiovascular diseases

Cardiovascular disease is one of the most common causes of death in the world. The risk of cardiovascular disease increases as we age. However, researchers are still partly in the dark as to why this is so. Until now, any model has been able to reveal the underlying biological processes.

Our heart changes as we age. It slowly gets bigger and stiffer, the arteries calcify and the pumping power deteriorates. In space, factors such as stress, microgravity and radiation cause those ageing processes to occur 20 times faster. So in space, we are speeding up time. And that gives us the unique opportunity to obtain research results that we simply cannot obtain here on Earth. The platform we will develop, will allow research into the mechanisms that drive cardiac ageing. This research will be fully automated and can be operated remotely,” says Hilde Stenuit, researcher at Space Applications Services.

Credit: AstroCardia

To examine a living human heart and all the processes associated with it in depth is practically impossible. That was why the researchers will bioprint a miniature heart on a chip and build an artificial circulatory system around it.

This ‘heart-on-a-chip’ is a chip of a few square millimetres on which heart muscle cells are printed. The ‘ink’ consists of biomaterials and stem cells that can develop into any possible cell in the body. The cells begin to divide and organise themselves into a developing human heart model – known as a cardiac organoid. An artificial circulatory system feeds that heart with stimuli, oxygen and nutrients until it matures and begins to beat. The scientists can conduct tests on it. The main test will be conducted in 2025, onboard the International Space Station.

This is when the heart-on-a-chip devices will be launched to space and kept alive for at least six weeks. During this period, they will be monitored in real time.  Once the devices returned to Earth, researchers from the company QbD and the nuclear research centre SCK CEN will analyse them in detail. With this space experiment, the partners hope to investigate whether the exposure of the developed cardiovascular system to the space environment can work as a scientific model of heart ageing.

The miniature heart, which is barely a chia seed’s size, faithfully mimics its human counterpart. The innovative technique would make it possible to better investigate cardiovascular diseases and test out some potential medicines. The biggest advantage is that we can personalize them by using stem cells from the patient themselves. As such, we can grow a miniature version of the patient’s heart. This would represent a great leap forward in personalized medicine,” Dr. Kevin Tabury, SCK CEN’s radiobiology expert says.

Bio-ink

To 3D bioprint a miniature heart model into a chip, specialist material is an absolute must. And that includes a 3D bioprinter with micrometric precision, living stem cells and ‘bio-ink’. Those stem cells developing into a mini organ must be printable and held together. This will require the expertise of BIO INX.

Compare it to bricklaying a wall. The stem cells are the bricks, the bio-ink the mortar. Bio-ink is a kind of gel, which makes cells printable and in which they can survive during and after printing,” says Jasper Van Hoorick, CEO at BIO INX.

Lastly, the R&D company Antleron will develop the artificial circulatory system.

With this project, we are looking beyond the horizon. We are already concerned today with the problems society will face tomorrow. A healthy heart is important not only for those currently suffering from cardiovascular disease, but also for healthy astronauts exploring space,” concludes Martijn Reniers, CIO at QbD.

 

Remember, you can post free of charge job opportunities in the AM Industry on 3D ADEPT Media or look for a job via our job board. Make sure to follow us on our social networks and subscribe to our weekly newsletter : FacebookTwitterLinkedIn & Instagram ! If you want to be featured in the next issue of our digital magazine or if you hear a story that needs to be heard, make sure to send it to contact@3dadept.com